International comparisons of intensive care: Meeting the challenges of different worlds of intensive care
暂无分享，去创建一个
[1] The changing challenges of critical care , 2004, Intensive Care Medicine.
[2] R. F. Johnston,et al. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .
[3] S. Opal,et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.
[4] R. Califf,et al. Holding GUSTO Up to the Light , 1994, Annals of Internal Medicine.
[5] J H Kerr,et al. Intensive Care Society's APACHE II study in Britain and Ireland--I: Variations in case mix of adult admissions to general intensive care units and impact on outcome. , 1993, BMJ.
[6] J H Kerr,et al. Intensive Care Society's APACHE II study in Britain and Ireland--II: Outcome comparisons of intensive care units after adjustment for case mix by the American APACHE II method. , 1993, BMJ.
[7] W. Knaus,et al. Patient selection for intensive care: a comparison of New Zealand and United States hospitals. , 1988, Critical care medicine.